Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice
NCT ID: NCT01657877
Last Updated: 2014-10-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
100 participants
INTERVENTIONAL
2012-05-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enamel Remineralization Potential of Dentifrices in Situ
NCT01128946
Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride
NCT01563172
Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation
NCT04155658
In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste
NCT03296072
Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions
NCT01641237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CSP/SMFP Dentifrice
Dentifrice containing high fluoride content as SMFP and CSP
Calcium sodium phosphosilicate
CSP high percentage weight by weight
Sodium monoflurophosphate
500 to 1500 parts per million (ppm) of fluoride
SMFP Dentifrice Prototype 1
Dentifrice containing high fluoride content as SMFP and no CSP
Sodium monoflurophosphate
500 to 1500 parts per million (ppm) of fluoride
SMFP Dentifrice Prototype 2
Dentifrice containing low fluoride content as SMFP and no CSP
Sodium monoflurophosphate
500 to 1500 parts per million (ppm) of fluoride
CSP Dentifrice
Dentifrice containing CSP but no fluoride
Calcium sodium phosphosilicate
CSP high percentage weight by weight
Placebo Dentifrice
Dentifrice containing no CSP and no fluoride
Placebo
No CSP and no fluoride
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Calcium sodium phosphosilicate
CSP high percentage weight by weight
Sodium monoflurophosphate
500 to 1500 parts per million (ppm) of fluoride
Placebo
No CSP and no fluoride
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University School of Dentistry
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RH01381
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.